BridgeMD
New treatment option for Critical Illness
Official title Hemodynamic Variations During Remote Ischemic Conditioning in Critical Ill Patients
ClinicalTrials.gov ID: NCT06536231
What this study is testing
- What it's testing
- The main objectives of this study are to evaluate the changes in hemodynamics occurring during the remote ischemic conditioning (RIC) procedure and to compare the hemodynamic responses elicited by passive leg raising before and after the RIC intervention.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- aged over 18 years,
- admitted to the intensive care unit,
- monitored with a transpulmonary thermodilution device with calibrated pulse contour analysis (Pulsion Medical Systems, Munich, Germany),
- decision by the physician in charge to perform passive leg raising.
You likely can't join if
- pregnancy,
- advanced malignancy,
- peripheral artery disease affecting both arms,
- head trauma,
- deep vein thrombosis in the lower limbs,
- intra-abdominal hypertension, defined as an intra-abdominal pressure greater than 12 mmHg.
The study team makes the final eligibility decision.
Where it's taking place
- Kaunas, Lithuania
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaunas, Lithuania. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.